therapies

Minaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testingMinaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testing

Minaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testing

New company unveiled at the annual ISCT conference in New Orleans combines two tenured and innovative CDMOs with a testing…

1 week ago
Leading Academic and Manufacturing Organizations Join Ori Biotechs Preferred Partner Network to Accelerate the Commercialization of Cell and Gene TherapiesLeading Academic and Manufacturing Organizations Join Ori Biotechs Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies

Leading Academic and Manufacturing Organizations Join Ori Biotechs Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies

Preferred Partner Network (PPN) members will become Centers of Excellence for the IRO® platform combining best-in-class technology with industry-leading development…

2 months ago
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell TherapiesTeknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation System March 11, 2025 19:00 ET  | Source:…

2 months ago
Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent DirectorAscend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today…

2 months ago
NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene TherapiesNewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies

NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies

March 05, 2025 03:00 ET  | Source: NewBiologix LAUSANNE, Switzerland, March 05, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a technology innovation…

2 months ago
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated DiseasesAlumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first…

3 months ago
Mycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBTMycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT

Mycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT

MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. dba AIBotics (“AIBotics” or the “Company”) (OTC: TPIA) and a…

3 months ago
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic OutlookAchievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

PALM BEACH, Fla., Dec. 26, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The breast cancer drugs market…

5 months ago
Tessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual MeetingTessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting

Tessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting

December 09, 2024 12:05 ET | Source: Tessera Therapeutics In vivo proof-of-concept achieved in humanized mice and non-human primates (NHPs)…

5 months ago
Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery TechnologiesContinuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

BRADENTON, Fla. and HOUSTON, Nov. 13, 2024 /PRNewswire/ -- Continuity Biosciences, LLC, a new bioscience company dedicated to developing and…

6 months ago